SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-021924
Filing Date
2022-02-14
Accepted
2022-02-14 09:38:03
Documents
2
Group Members
PITANGO H.T. FUND I, L.P.PITANGO HEALTHTECH FUND I - ISRAEL L.P.PITANGO HEALTHTECH PRINCIPALS FUND I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm226580d3_sc13g.htm SC 13G 82739
2 EXHIBIT 1 tm226580d3_ex-1.htm EX-99.1 8829
  Complete submission text file 0001104659-22-021924.txt   93214
Mailing Address 11 HAMENOFIM STREET BUILDING B HERZLIYA L3 46725
Business Address 11 HAMENOFIM STREET BUILDING B HERZLIYA L3 46725 97299718100
Pitango HealthTech Fund I, L.P. (Filed by) CIK: 0001775340 (see all company filings)

IRS No.: 981485171 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92700 | Film No.: 22626299
SIC: 2836 Biological Products, (No Diagnostic Substances)